Table of Content


Growth Environment
Key Highlights
Regional Impact of the COVID-19 Pandemic
Top Pharmaceuticals Industry Predictions for 2022
Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Pharmaceuticals Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Market Trends
Market Segmentation and Scope
Key Trend 1—Strategies to Fight Long COVID-19
Key Trend 2—Data-driven R&D Approach
Key Trend 3—Intense Conflict between Affordability and Access
Key Trend 4—Biologics Driving Manufacturing Capacity and Capability Expansion
Global Pharmaceuticals Industry—R&D Expenditure Outlook
Key Therapeutic Areas Outlook
Biopharmaceuticals’ VC Investments and M&A Outlook
Macroeconomic Factors
Global GDP Growth
2022 Scenario Analysis—Quarterly Global Growth
Supply Chain Disruptions—Impact Analysis
Sustainability Initiatives—Impact Analysis
Revenue Trends, 2021
Global Pharmaceuticals Industry—Historic Sales and Forecast
Segment Performance—Historic Sales and Forecast
Revenue Forecast by Region
Key Predictions for 2022
Prediction 1
Prediction 2
Prediction 3
Prediction 4
Prediction 5
Small-molecules Segment Outlook, 2022
Small-molecules Market Snapshot, 2022
Small-molecules Market—Companies to Watch
Biologics Segment Outlook, 2022
Biologics Market Snapshot, 2022
Biologics Market—Companies to Watch
Growth Opportunity Universe
Growth Opportunity 1—Innovative Formulation and Delivery Technologies for RNA Therapeutics, 2022
Growth Opportunity 1—Innovative Formulation and Delivery Technologies for RNA Therapeutics, 2022 (continued)
Growth Opportunity 2—Contract Research, Development, and Manufacturing Services to Support Emerging Biopharmaceuticals Companies in Asia-Pacific, 2022
Growth Opportunity 2—Contract Research, Development, and Manufacturing Services to Support Emerging Biopharmaceuticals Companies in Asia-Pacific, 2022 (continued)
Growth Opportunity 3—Digital Therapeutics to Support Evidence-based Treatment and Medication Adherence in the EU, 2022
Growth Opportunity 3—Digital Therapeutics to Support Evidence-based Treatment and Medication Adherence in the EU, 2022 (continued)
Conclusions
Key Concluding Thoughts
Appendix
Market Definition—Pharmaceuticals and Biotechnology
Next Steps
Your Next Steps